These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

772 related articles for article (PubMed ID: 32430456)

  • 1. Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?
    Sardu C; D'Onofrio N; Balestrieri ML; Barbieri M; Rizzo MR; Messina V; Maggi P; Coppola N; Paolisso G; Marfella R
    Diabetes Care; 2020 Jul; 43(7):1408-1415. PubMed ID: 32430456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].
    Ma WX; Ran XW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):146-150. PubMed ID: 32220179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
    Zhang J; Kong W; Xia P; Xu Y; Li L; Li Q; Yang L; Wei Q; Wang H; Li H; Zheng J; Sun H; Xia W; Liu G; Zhong X; Qiu K; Li Y; Wang H; Wang Y; Song X; Liu H; Xiong S; Liu Y; Cui Z; Hu Y; Chen L; Pan A; Zeng T
    Front Endocrinol (Lausanne); 2020; 11():525. PubMed ID: 32754119
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperglycemia is a strong predictor of poor prognosis in COVID-19.
    Liu SP; Zhang Q; Wang W; Zhang M; Liu C; Xiao X; Liu Z; Hu WM; Jin P
    Diabetes Res Clin Pract; 2020 Sep; 167():108338. PubMed ID: 32712122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Study of Hyperglycemia and SARS-CoV-2 Infection in Intensive Care Unit Patients.
    Ilias I; Jahaj E; Kokkoris S; Zervakis D; Temperikidis P; Magira E; Pratikaki M; Vassiliou AG; Routsi C; Kotanidou A; Dimopoulou I
    In Vivo; 2020; 34(5):3029-3032. PubMed ID: 32871848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues for the management of people with diabetes and COVID-19 in ICU.
    Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
    Cardiovasc Diabetol; 2020 Jul; 19(1):114. PubMed ID: 32690029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study.
    Coppelli A; Giannarelli R; Aragona M; Penno G; Falcone M; Tiseo G; Ghiadoni L; Barbieri G; Monzani F; Virdis A; Menichetti F; Del Prato S;
    Diabetes Care; 2020 Oct; 43(10):2345-2348. PubMed ID: 32788285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study.
    Li Y; Han X; Alwalid O; Cui Y; Cao Y; Liu J; Gu J; Wang L; Fan Y; Shi H
    Diabetes Res Clin Pract; 2020 Aug; 166():108299. PubMed ID: 32623030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.
    Bode B; Garrett V; Messler J; McFarland R; Crowe J; Booth R; Klonoff DC
    J Diabetes Sci Technol; 2020 Jul; 14(4):813-821. PubMed ID: 32389027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes and COVID-19 infection].
    Kosinski C; Zanchi A; Wojtusciszyn A
    Rev Med Suisse; 2020 May; 16(692):939-943. PubMed ID: 32374541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients.
    Marfella R; Paolisso P; Sardu C; Bergamaschi L; D'Angelo EC; Barbieri M; Rizzo MR; Messina V; Maggi P; Coppola N; Pizzi C; Biffi M; Viale P; Galié N; Paolisso G
    Diabetes Metab; 2020 Oct; 46(5):403-405. PubMed ID: 32447102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is subcutaneous insulin administration adequate for the management of hyperglycemic crisis in COVID-19?
    Permana H; Soetedjo NNM
    Diabetes Metab Syndr; 2020; 14(5):947-948. PubMed ID: 32599534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
    Fadini GP; Morieri ML; Boscari F; Fioretto P; Maran A; Busetto L; Bonora BM; Selmin E; Arcidiacono G; Pinelli S; Farnia F; Falaguasta D; Russo L; Voltan G; Mazzocut S; Costantini G; Ghirardini F; Tresso S; Cattelan AM; Vianello A; Avogaro A; Vettor R
    Diabetes Res Clin Pract; 2020 Oct; 168():108374. PubMed ID: 32805345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
    Singh AK; Singh R
    Diabetes Res Clin Pract; 2020 Sep; 167():108382. PubMed ID: 32853686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
    Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
    Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19.
    Sardu C; Gargiulo G; Esposito G; Paolisso G; Marfella R
    Cardiovasc Diabetol; 2020 Jun; 19(1):76. PubMed ID: 32527257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
    Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
    Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.
    Wu J; Huang J; Zhu G; Wang Q; Lv Q; Huang Y; Yu Y; Si X; Yi H; Wang C; Liu Y; Xiao H; Zhou Q; Liu X; Yang D; Guan X; Li Y; Peng S; Sung J; Xiao H
    BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32503812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.